MedStartr And The Brave New World Of Healthtech Crowdfunding
This article was originally published in The Pink Sheet Daily
MedStartr is at the head of a wave of crowdfunding startups focused on health and wellness technology. Co-founder Alex Fair says the crowdfunding provisions in the JOBS Act will enable the field, but the SEC still needs to set the ground rules. Meanwhile, sites like MedStartr are operating in limbo as non-equity based seed funders of small ideas.
You may also be interested in...
Mesenchymal cell specialist Mesoblast came back from a near-death experience in 2016 when Teva returned a key asset. But recent success in a Phase III trial in acute GVHD has brought it some attention. Now it needs to repeat the achievement in advanced heart failure and find a partner for its burgeoning pipeline.
Pharmas have shied away from the challenging antidepressant market in recent years, but two late-stage ketamine-like candidates are leading the pack of novel agents in development.
Retail health clinics are undergoing an intense period of partnering and business model change. Although the value proposition is rock solid, the real test will be whether clinics can offer complementary services to traditional primary care, and working with provider groups, help achieve the goal of population health management.